Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Xianjun Yu is a pioneering surgical oncologist whose work has fundamentally reshaped the landscape of minimally invasive pancreatic surgery. His primary research focus is the development and validation of advanced laparoscopic and robotic techniques for treating complex pancreatic diseases, including pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasms. Dr. Yu’s major contributions include championing the safety and feasibility of laparoscopic pancreaticoduodenectomy (LPD), a procedure he has helped bring into the mainstream, as evidenced by his highly cited 2019 work (35 citations). He has also broken new ground by demonstrating that tumors involving the main pancreatic duct are no longer a contraindication for minimally invasive enucleation, a paradigm-shifting achievement detailed in his 2023 study (10 citations). His leadership in establishing the "Chinese expert consensus on minimally invasive radical surgery for pancreatic ductal adenocarcinoma" (2022) has standardized best practices across a nation. With a career marked by technical innovation—including early adoption of the da Vinci Xi robot for oncology (2015, 20 citations)—Dr. Yu continues to expand the boundaries of what is possible, making complex pancreatic surgery safer and less invasive for patients worldwide.